Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Trébucq

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 5, 2007
Tuberculosis and big citiesArnaud Trébucq
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Fake news for XpertArnaud Trébucq
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 18, 2003
Drug packaging: would 'blister packs' improve compliance and is 'one-box, one patient' of interest for TB control programmes?Arnaud Trébucq
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 21, 2004
Revisiting sputum smear microscopyArnaud Trébucq
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 16, 2015
Widespread use of Xpert(®) MTB/RIF will most probably reduce the total number of TB cases notifiedArnaud Trébucq, Santha Devi
The European Respiratory Journal|February 16, 2018
Tuberculosis re-treatment after exclusion of rifampicin resistanceChen-Yuan Chiang, Arnaud Trébucq
The European Respiratory Journal|February 14, 2018
Should gatifloxacin be included in the model list of essential medicines?Chen-Yuan Chiang, Arnaud Trébucq, Alberto Piubello, et al.
The European Respiratory Journal|June 6, 2020
The looming threat of bedaquiline resistance in tuberculosisChen-Yuan Chiang, Arnaud Trébucq, Alberto Piubello, et al.
Lancet (London, England)|July 30, 2019
Multidrug-resistant tuberculosisChen-Yuan Chiang, Armand Van Deun, Arnaud Trébucq, et al.
Plos One|April 24, 2014
National profile and treatment outcomes of patients with extrapulmonary tuberculosis in BéninSerge Ade, Anthony D Harries, Arnaud Trébucq, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 5, 2007
Tuberculosis and big citiesArnaud Trébucq
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Fake news for XpertArnaud Trébucq
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 18, 2003
Drug packaging: would 'blister packs' improve compliance and is 'one-box, one patient' of interest for TB control programmes?Arnaud Trébucq
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 21, 2004
Revisiting sputum smear microscopyArnaud Trébucq
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 16, 2015
Widespread use of Xpert(®) MTB/RIF will most probably reduce the total number of TB cases notifiedArnaud Trébucq, Santha Devi
The European Respiratory Journal|February 16, 2018
Tuberculosis re-treatment after exclusion of rifampicin resistanceChen-Yuan Chiang, Arnaud Trébucq
The European Respiratory Journal|February 14, 2018
Should gatifloxacin be included in the model list of essential medicines?Chen-Yuan Chiang, Arnaud Trébucq, Alberto Piubello, et al.
The European Respiratory Journal|June 6, 2020
The looming threat of bedaquiline resistance in tuberculosisChen-Yuan Chiang, Arnaud Trébucq, Alberto Piubello, et al.
Lancet (London, England)|July 30, 2019
Multidrug-resistant tuberculosisChen-Yuan Chiang, Armand Van Deun, Arnaud Trébucq, et al.
Plos One|April 24, 2014
National profile and treatment outcomes of patients with extrapulmonary tuberculosis in BéninSerge Ade, Anthony D Harries, Arnaud Trébucq, et al.
Pageof 2